|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang AP, Liu J, Lei HY, Zhang QW, Zhao L
and Yang GH: CA72-4 combined with CEA, CA125 and CAl9-9 improves
the sensitivity for the early diagnosis of gastric cancer. Clin
Chim Acta. 437:183–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zeng S, Xiao YF, Tang B, Hu CJ, Xie R,
Yang SM and Li BS: Long noncoding RNA in digestive tract cancers:
Function, mechanism, and potential biomarker. Oncologist.
20:898–906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun TT, He J, Liang Q, Ren LL, Yan TT, Yu
TC, Tang JY, Bao YJ, Hu Y, Lin Y, et al: LncRNA GClnc1 promotes
gastric carcinogenesis and may act as a modular scaffold of WDR5
and KAT2A complexes to specify the histone modification pattern.
Cancer Discov. 6:784–801. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: LncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1 and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang K, Shi H, Xi H, Wu X, Cui J, Gao Y,
Liang W, Hu C, Liu Y, Li J, et al: Genome-wide lncRNA microarray
profiling identifies novel circulating lncRNAs for detection of
gastric cancer. Theranostics. 7:213–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, He Y, Liu W, Bai S, Xiao L, Zhang
J, Dhanasekaran SM, Wang Z, Kalyana-Sundaram S, Balbin OA, et al:
Non-coding RNA LINC00857 is predictive of poor patient survival and
promotes tumor progression via cell cycle regulation in lung
cancer. Oncotarget. 7:11487–11499. 2016.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCTmethod. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu Y, Wang J, Qian J, Kong X, Tang J, Wang
Y, Chen H, Hong J, Zou W, Chen Y, et al: Long noncoding RNA GAPLINC
regulates CD44-dependent cell invasiveness and associates with poor
prognosis of gastric cancer. Cancer Res. 74:6890–6902. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu X, Tian X, Yu C, Shen C, Yan T, Hong
J, Wang Z, Fang JY and Chen H: A long non-coding RNA signature to
improve prognosis prediction of gastric cancer. Mol Cancer.
15:602016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Chen H, Chen S, Mo X, Li T, Xiao B,
Yu R and Guo J: Circular RNA 0000096 affects cell growth and
migration in gastric cancer. Br J Cancer. 116:626–633. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leung SY, Ho C, Tu IP, Li R, So S, Chu KM,
Yuen ST and Chen X: Comprehensive analysis of 19q12 amplicon in
human gastric cancers. Mod Pathol. 19:854–863. 2006. View Article : Google Scholar : PubMed/NCBI
|
